Head-to-head comparisons of medication uses, side effects, warnings, and more.
Kesimpta (ofatumumab)
Fingolimod (Gilenya)
Kesimpta (ofatumumab)
Fingolimod (Gilenya)
Summary of Kesimpta vs. Gilenya
Summary for Monoclonal antibody
Prescription only
Kesimpta (ofatumumab) is an injectable medication for adults with relapsing forms of multiple sclerosis (MS). It works as a monoclonal antibody to help lessen MS flare-ups that come and go. Kesimpta (ofatumumab) is injected under the skin. You can use the Kesimpta prefilled syringes or Sensoready Pens to inject. After the first 3 weekly injections, you inject the medication once a month. Some common side effects include a higher risk of infections, pain or swelling at the injection site, and headache.
Summary for Sphingosine 1-phosphate receptor modulator
Prescription only
Fingolimod (Gilenya) is a disease-modifying treatment option for relapsing multiple sclerosis (MS). It works well to lower the number of MS relapses. Fingolimod (Gilenya) is taken by mouth, typically once daily, and can be used by adults and children age 10 years and older. But fingolimod (Gilenya) can cause potentially serious side effects, such as a higher risk for infections and heart problems, so it's not the best choice for everyone.